Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

[Contribution of hyperandrogenism to the development of metabolic syndrome in obese women with polycystic ovary syndrome].

Rehme MF, Pontes AG, Corrente JE, Franco JG Jr, Pontes A.

Rev Bras Ginecol Obstet. 2013 Dec;35(12):562-8. Portuguese.

2.

Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.

Amato MC, Galluzzo A, Merlino S, Mattina A, Richiusa P, Criscimanna A, Giordano C.

Eur J Endocrinol. 2006 Dec;155(6):859-65.

3.
4.
5.

Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.

Wijeyaratne CN, Seneviratne Rde A, Dahanayake S, Kumarapeli V, Palipane E, Kuruppu N, Yapa C, Seneviratne Rde A, Balen AH.

Hum Reprod. 2011 Jan;26(1):202-13. doi: 10.1093/humrep/deq310. Epub 2010 Nov 23.

PMID:
21098627
6.

Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.

Zhang HY, Guo CX, Zhu FF, Qu PP, Lin WJ, Xiong J.

Arch Gynecol Obstet. 2013 Mar;287(3):525-31. doi: 10.1007/s00404-012-2568-z. Epub 2012 Oct 30.

PMID:
23108387
7.

Prevalence of metabolic syndrome is higher among non-obese PCOS women with hyperandrogenism and menstrual irregularity in Korea.

Kim MJ, Lim NK, Choi YM, Kim JJ, Hwang KR, Chae SJ, Park CW, Choi DS, Kang BM, Lee BS, Kim T, Park HY.

PLoS One. 2014 Jun 5;9(6):e99252. doi: 10.1371/journal.pone.0099252. eCollection 2014.

8.

Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.

Becerra-Fernández A, Pérez-López G, Román MM, Martín-Lazaro JF, Lucio Pérez MJ, Asenjo Araque N, Rodríguez-Molina JM, Berrocal Sertucha MC, Aguilar Vilas MV.

Endocrinol Nutr. 2014 Aug-Sep;61(7):351-8. doi: 10.1016/j.endonu.2014.01.010. Epub 2014 Mar 26. English, Spanish.

PMID:
24680383
9.

Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.

Ezeh U, Pall M, Mathur R, Azziz R.

Hum Reprod. 2014 Jul;29(7):1508-17. Epub 2014 May 9.

10.

Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome.

Alpañés M, Luque-Ramírez M, Martínez-García MÁ, Fernández-Durán E, Álvarez-Blasco F, Escobar-Morreale HF.

Fertil Steril. 2015 Mar;103(3):795-801.e2. doi: 10.1016/j.fertnstert.2014.12.105. Epub 2015 Jan 10.

PMID:
25585504
11.

[Exploration of the classification of polycystic ovarian syndrome].

Lin JF, Li X, Zhu MW.

Zhonghua Fu Chan Ke Za Zhi. 2006 Oct;41(10):684-8. Chinese.

PMID:
17199924
12.

Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism.

Castelo-Branco C, Steinvarcel F, Osorio A, Ros C, Balasch J.

Gynecol Endocrinol. 2010 Oct;26(10):736-42. doi: 10.3109/09513590.2010.481025.

PMID:
20569105
13.

Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies?

Meirow D, Raz I, Yossepowitch O, Brzezinski A, Rosler A, Schenker JG, Berry EM.

Hum Reprod. 1996 Sep;11(9):1848-53.

PMID:
8921052
14.

Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.

Schmidt TH, Khanijow K, Cedars MI, Huddleston H, Pasch L, Wang ET, Lee J, Zane LT, Shinkai K.

JAMA Dermatol. 2016 Apr;152(4):391-8. doi: 10.1001/jamadermatol.2015.4498.

PMID:
26720591
15.

Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.

Wu J, Zhu Y, Jiang Y, Cao Y.

Gynecol Endocrinol. 2008 Jul;24(7):392-8. doi: 10.1080/09513590802217027.

PMID:
18608522
16.

Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.

Espinós-Gómez JJ, Rodriguez-Espinosa J, Ordóñez-Llanos J, Calaf-Alsina J.

Gynecol Endocrinol. 2012 Apr;28(4):264-8. doi: 10.3109/09513590.2011.613968. Epub 2011 Oct 1.

PMID:
21962027
17.

Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome.

Huang R, Zheng J, Li S, Tao T, Ma J, Liu W.

Acta Obstet Gynecol Scand. 2015 May;94(5):494-500. doi: 10.1111/aogs.12612. Epub 2015 Mar 19.

PMID:
25711494
18.

Impact of sleep-disordered breathing on metabolic dysfunctions in patients with polycystic ovary syndrome.

Chatterjee B, Suri J, Suri JC, Mittal P, Adhikari T.

Sleep Med. 2014 Dec;15(12):1547-53. doi: 10.1016/j.sleep.2014.06.023. Epub 2014 Sep 16.

PMID:
25311833
19.

Plasma selenium levels in Turkish women with polycystic ovary syndrome.

Coskun A, Arikan T, Kilinc M, Arikan DC, Ekerbiçer HÇ.

Eur J Obstet Gynecol Reprod Biol. 2013 Jun;168(2):183-6. doi: 10.1016/j.ejogrb.2013.01.021. Epub 2013 Mar 13.

PMID:
23490536
20.

The insulin-resistant phenotype of polycystic ovary syndrome.

Svendsen PF, Madsbad S, Nilas L.

Fertil Steril. 2010 Aug;94(3):1052-8. doi: 10.1016/j.fertnstert.2009.04.008. Epub 2009 Jul 5.

PMID:
19580964

Supplemental Content

Support Center